Valeant Pharmaceuticals Intl Inc Stock Price (NYSE:VRX)

Add to My Stocks
$11.18 $0.5 (4.68%) VRX stock closing price Mar 29, 2017 (Closing)
YOUR DAILY UPDATE ON
VRX
Valeant Pharmaceuticals Intl Inc
29 MAR 2017
amigobulls logo
VRX hand_up
VRX vs S&P 500
Closing Price: Mar 29, 2017
VRX
$11.18 ( 4.68%)
S&P 500
2361.1 ( 0.11%)
VRX
52 Week Price Range
1 Year Return: -63.15%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-24.9%
PE Valuation
Cheaper*
home image
Rating
VRX AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Valeant Pharmaceuticals Intl Inc Snapshot Video

55 5 2

VRX Stock Details

Prev Close* : $10.68
Market Cap:
$3.71B
Day Low: $10.67
52 Week Low: $10.35
Open: $10.68
Volume: 26944434
Day High: $11.43
52 Week High: $38.50
Dividend:
N/A

Valeant Pharmaceuticals Intl Inc Stock Articles & Video

more news on VRX stock

Valeant Pharmaceuticals Intl Inc News - From Partners

Biotech Bull Making a Comeback   by Zacks on Mar 21, 2017

VRX Stockcharts

View VRX PE ratio, PS ratio stocks charts and compare with peers.
VRX Chart
Note: Compare Valeant Pharmaceuticals Intl Inc stock price history with the index and industry peers.

Valeant Pharmaceuticals Intl Inc Valuation

PS ratio (
price to sales ratio
)
0.4
PB ratio (
price to book ratio
)
0.79

Valeant Pharmaceuticals Intl Inc Financial Ratios

Asset Turnover
0.22
Receivables Turnover
3.63
Debt to Equity
9.16

Top Stock Gainers

show top losers
CompanyPriceChange (%)
No top gainers from Medical-Drugs industry
CompanyPriceChange (%)
No top losers from Medical-Drugs industry

Valeant Pharmaceuticals Intl Inc Stock News - Partner Headlines

Valeant Pharmaceuticals Intl Inc Financial Statements

income statement20152014201320122011
Net Sales Or Revenues10.45B8.26B5.77B3.55B2.46B
Net Income-291.7M913.5M-866.14M-116.02M159.55M
Total Operating Expense6.33B3.97B4.27B2.43B1.44B
view Valeant Pharmaceuticals Intl Inc income statement
balance sheet20152014201320122011
Total Assets48.96B26.35B27.97B17.95B13.14B
Total Liabilities42.93B20.92B22.74B14.23B9.13B
Shareholders Equity6.03B5.43B5.23B3.72B4.01B
view Valeant Pharmaceuticals Intl Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-822.2M-668.4M-378.29M-253.27M-132.97M
Net Cash From (Used By) Operating Activities2.2B2.29B1.04B656.57M676.47M
Increase (Decrease) In Prop Plant And Equipment-222.4M1.2B-74.22M-15.64M-58.51M
view Valeant Pharmaceuticals Intl Inc cashflow statement

Valeant Pharmaceuticals Intl Inc Stock Message Board

Valeant Pharmaceuticals Intl Inc stock lost -1.2 %, and the last close price as of 28 Mar, 2017 is 10.68 for VRX stock. Valeant Pharmaceuticals Intl Inc market capitalization is 3.76B and it represents the total market value of VRX stock. Valeant Pharmaceuticals Intl Inc valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Valeant Pharmaceuticals Intl Inc stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 8421556 VRX shares were traded yesterday, and Valeant Pharmaceuticals Intl Inc stock chart shows that the VRX stock quote hit a day high of 10.83 and day low of 10.66. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Valeant Pharmaceuticals Intl Inc stock price history, gives the entire historical data for VRX stock.